Free Trial

Canada Pension Plan Investment Board Makes New Investment in agilon health, inc. (NYSE:AGL)

agilon health logo with Medical background

Canada Pension Plan Investment Board acquired a new stake in shares of agilon health, inc. (NYSE:AGL - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 100,300 shares of the company's stock, valued at approximately $191,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Oak Thistle LLC acquired a new stake in agilon health in the 4th quarter worth about $25,000. Ieq Capital LLC acquired a new position in shares of agilon health in the 4th quarter valued at $26,000. Signaturefd LLC increased its holdings in shares of agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after buying an additional 8,467 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of agilon health in the 4th quarter worth $33,000. Finally, Cerity Partners LLC acquired a new position in agilon health in the fourth quarter valued at $34,000.

Wall Street Analyst Weigh In

A number of research firms have recently commented on AGL. JMP Securities restated a "market perform" rating on shares of agilon health in a report on Monday. Royal Bank of Canada lifted their price target on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. TD Cowen increased their price objective on shares of agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. Robert W. Baird reduced their target price on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Finally, Citigroup upgraded agilon health from a "neutral" rating to a "buy" rating and increased their price target for the company from $3.25 to $5.00 in a report on Friday, April 25th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $4.81.

Read Our Latest Stock Analysis on AGL

agilon health Stock Down 6.7 %

Shares of AGL stock traded down $0.29 during mid-day trading on Thursday, reaching $3.98. 1,343,718 shares of the company were exchanged, compared to its average volume of 4,845,742. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The business's 50 day simple moving average is $4.21 and its 200 day simple moving average is $3.16. The company has a market capitalization of $1.64 billion, a P/E ratio of -4.23 and a beta of 0.38. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73.

About agilon health

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines